The efficacy of solifenacin 5/10mg on ‘urgency’ endpoints in different OAB patient populations: subanalysis of results from the randomised, double-blind SUNRISE study

Abstract Category

Detrusor Overactivity

Links
	Abstract 192
	Non-Discussion Posters Scientific Non Discussion Poster Session 19
	1. King’s College Hospital, Department of Urogynaecology, London, UK, 2. Astellas Pharma Europe BV, Clinical Data Sciences, Leiderdorp, The Netherlands, 3. Astellas Pharma Europe Ltd, Medical Affairs, Staines, UK
Abstract PDF Edit Abstract Abstract Centre